MYDA Advisors’s Inspire Medical Systems INSP Stock Holding History

MYDA Advisors’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-38,000	Closed	-$1.6M	–	94
2018 Q3	$1.6M	Buy	+38,000	New	+$1.78M	0.86%	30

Other funds holding INSP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

KXA

KPCB XII Associates Menlo Park, California $738K AUM 3.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

MYDA Advisors's INSP Position: Q4 2018 in Review

MYDA Advisors sold out of Inspire Medical Systems (INSP) in Q4 2018, closing a stake of 38,000 shares — an estimated $1.6M sold.

MYDA Advisors first reported a position in INSP in Q3 2018 and held it in 1 quarter. The position peaked at $1.6M in Q3 2018. 103 funds tracked by Wall St. Rank hold INSP as of Q4 2018.

MYDA Advisors reported no remaining Inspire Medical Systems position as of Q4 2018 after selling out during the quarter.
MYDA Advisors sold 38,000 Inspire Medical Systems shares in Q4 2018, an estimated $1.6M.
MYDA Advisors first reported a position in Inspire Medical Systems in Q3 2018 and held it in 1 quarter.
MYDA Advisors's Inspire Medical Systems position peaked at $1.6M in Q3 2018.
103 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2018.

Based on MYDA Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.